Authors:
VANROGGEN JFG
NOORDIJK EM
VANKRIEKEN JHJM
Citation: Jfg. Vanroggen et al., SMALL-CELL ANAPLASTIC CARCINOMA OF THE ESOPHAGUS FOLLOWING MANTLE FIELD RADIOTHERAPY FOR MEDIASTINAL HODGKINS LYMPHOMA - FIRST CASE-REPORT, European journal of cancer, 34(9), 1998, pp. 1469-1469
Authors:
TIRELLI U
ERRANTE D
VANGLABBEKE M
TEODOROVIC I
KLUINNELEMANS JC
THOMAS J
BRON D
ROSTI G
SOMERS R
ZAGONEL V
NOORDIJK EM
Citation: U. Tirelli et al., CHOP IS THE STANDARD REGIMEN IN PATIENTS GREATER-THAN-OR-EQUAL-TO-70 YEARS OF AGE WITH INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE STUDY-GROUP, Journal of clinical oncology, 16(1), 1998, pp. 27-34
Authors:
JANSEN SJT
STIGGELBOUT AM
NOOY MA
NOORDIJK EM
KIEVIT J
Citation: Sjt. Jansen et al., UNSTABLE PREFERENCES - A SHIFT IN VALUATION OR AN EFFECT OF THE ELICITATION PROCEDURE, Medical decision making, 18(4), 1998, pp. 469-469
Citation: P. Carde et Em. Noordijk, STUDYING SPREADING PATTERN IN HODGKINS-DISEASE - IS IT RELEVANT TO MODERN CANCER-TREATMENT, Radiotherapy and oncology, 47(1), 1998, pp. 3-5
Authors:
KROL AD
HERMANS J
DAWSON L
SNIJDER S
WIJERMANS PW
KLUINNELEMANS HC
KLUIN PM
VANKRIEKEN JH
NOORDIJK EM
Citation: Ad. Krol et al., TREATMENT, PATTERNS OF FAILURE, AND SURVIVAL OF PATIENTS WITH STAGE-INODAL AND EXTRANODAL NON-HODGKINS-LYMPHOMAS, ACCORDING TO DATA IN THEPOPULATION-BASED REGISTRY OF THE COMPREHENSIVE CANCER CENTER WEST, Cancer, 83(8), 1998, pp. 1612-1619
Authors:
VANDERMAAZEN RWM
NOORDIJK EM
THOMAS J
RAEMAEKERS JMM
MEERWALDT JH
Citation: Rwm. Vandermaazen et al., COMBINED-MODALITY TREATMENT IS THE TREATMENT OF CHOICE FOR STAGE I IEINTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS/, British Journal of Haematology, 102(1), 1998, pp. 149-149
Authors:
ONG F
HERMANS J
NOORDIJK EM
DEKIEVIET W
SEELEN PJ
WIJERMANS PW
KLUINNELEMANS JC
Citation: F. Ong et al., DEVELOPMENT OF A MYELOMA RISK SCORE USING A POPULATION-BASED REGISTRYON PARAPROTEINEMIA AND MYELOMA, Leukemia & lymphoma, 27(5-6), 1997, pp. 495-501
Authors:
MEERWALDT JH
CARDE P
SOMERS R
THOMAS J
KLUINNELEMANS JC
BRON D
NOORDIJK EM
COSSET JM
BIJNENS L
TEODOROVIC I
HAGENBEEK A
Citation: Jh. Meerwaldt et al., PERSISTENT IMPROVED RESULTS AFTER ADDING VINCRISTINE AND BLEOMYCIN TOA CYCLOPHOSPHAMIDE HYDROXORUBICIN/VM-26/PREDNISONE COMBINATION (CHVMP) IN STAGE III-IV INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA/, Annals of oncology, 8, 1997, pp. 67-70
Authors:
ONG F
HERMANS J
NOORDIJK EM
DEKIEVIET W
WIJERMANS PW
SEELEN PJ
SNIJDER S
OOSTINDIER MJ
KLUINNELEMANS JC
Citation: F. Ong et al., DEVELOPING A POPULATION-BASED REGISTRY FOR PATIENTS WITH PARAPROTEINEMIAS OR MULTIPLE-MYELOMA, Journal of clinical epidemiology, 50(8), 1997, pp. 909-915
Authors:
NOORDIJK EM
CARDE P
HAGENBEEK A
MANDARD AM
KLUINNELEMANS J
THOMAS J
TIRELLI U
MONCONDUIT M
EGHBALI H
BURGERS JMV
DUPOUY N
HENRYAMAR M
Citation: Em. Noordijk et al., COMBINATION OF RADIOTHERAPY AND CHEMOTHERAPY IS ADVISABLE IN ALL PATIENTS WITH CLINICAL STAGE I-II HODGKINS-DISEASE, 6-YEAR RESULTS OF THE EORTC-GPMC CONTROLLED CLINICAL-TRIALS H7-VF, H7-F AND H7-U, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 173-173
Authors:
KROL AD
HERMANS J
KRAMER MH
KLUIN PM
KLUINNELEMANS HC
BLOK P
HEERING KJ
NOORDIJK EM
VANKRIEKEN JH
Citation: Ad. Krol et al., GASTRIC LYMPHOMAS COMPARED WITH LYMPH-NODE LYMPHOMAS IN A POPULATION-BASED REGISTRY DIFFER IN STAGE DISTRIBUTION AND DISSEMINATION PATTERNSBUT NOT IN PATIENT SURVIVAL, Cancer, 79(2), 1997, pp. 390-397
Authors:
RIJLAARSDAM JU
TOONSTRA J
MEIJER OWM
NOORDIJK EM
WILLEMZE R
Citation: Ju. Rijlaarsdam et al., TREATMENT OF PRIMARY CUTANEOUS B-CELL LYMPHOMAS OF FOLLICLE CENTER CELL ORIGIN - A CLINICAL FOLLOW-UP-STUDY OF 55 PATIENTS TREATED WITH RADIOTHERAPY OR POLYCHEMOTHERAPY, Journal of clinical oncology, 14(2), 1996, pp. 549-555
Authors:
KROL ADG
AUSSEMS P
NOORDIJK EM
HERMANS J
LEER JWH
Citation: Adg. Krol et al., LOCAL IRRADIATION ALONE FOR PERIPHERAL STAGE-I LUNG-CANCER - COULD WEOMIT THE ELECTIVE REGIONAL NODAL IRRADIATION, International journal of radiation oncology, biology, physics, 34(2), 1996, pp. 297-302
Authors:
PITTALUGA S
BIJNENS L
TEODOROVIC I
HAGENBEEK A
MEERWALDT JH
SOMERS R
THOMAS J
NOORDIJK EM
DEWOLFPEETERS C
Citation: S. Pittaluga et al., CLINICAL ANALYSIS OF 670 CASES IN 2 TRIALS OF THE EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER LYMPHOMA COOPERATIVE GROUPSUBTYPED ACCORDING TO THE REVISED EUROPEAN-AMERICAN CLASSIFICATION OFLYMPHOID NEOPLASMS - A COMPARISON WITH THE WORKING FORMULATION, Blood, 87(10), 1996, pp. 4358-4367
Authors:
NOOY MA
FIBBE W
OUWERKERK J
VANBENTHEM D
NOORDIJK EM
Citation: Ma. Nooy et al., HIGH-DOSE CHEMOTHERAPY (HDC) WITH STEMCELL RESCUE FOR PATIENTS WITH METASTATIC EWINGS-SARCOMA, European journal of cancer, 31A, 1995, pp. 1202-1202
Authors:
ONG F
HERMANS J
NOORDIJK EM
WIJERMANS PW
KLUINNELEMANS JC
Citation: F. Ong et al., PRESENTING SIGNS AND SYMPTOMS IN MULTIPLE-MYELOMA - HIGH PERCENTAGES OF STAGE-III AMONG PATIENTS WITHOUT APPARENT MYELOMA-ASSOCIATED SYMPTOMS, Annals of hematology, 70(3), 1995, pp. 149-152
Authors:
ONG F
HERMANS J
NOORDIJK EM
KLUINNELEMANS JC
Citation: F. Ong et al., IS THE DURIE AND SALMON DIAGNOSTIC CLASSIFICATION-SYSTEM FOR PLASMA-CELL DYSCRASIAS STILL THE BEST CHOICE - APPLICATION OF 3 CLASSIFICATIONSYSTEMS TO A LARGE POPULATION-BASED REGISTRY OF PARAPROTEINEMIA AND MULTIPLE-MYELOMA, Annals of hematology, 70(1), 1995, pp. 19-24
Authors:
TEODOROVIC I
PITTALUGA S
KLUINNELEMANS JC
MEERWALDT JH
HAGENBEEK A
VANGLABBEKE M
SOMERS R
BIJNENS L
NOORDIJK EM
PEETERS CD
Citation: I. Teodorovic et al., EFFICACY OF 4 DIFFERENT REGIMENS IN 64 MANTLE-CELL LYMPHOMA CASES - CLINICOPATHOLOGICAL COMPARISON WITH 498 OTHER NON-HODGKINS-LYMPHOMA SUBTYPES, Journal of clinical oncology, 13(11), 1995, pp. 2819-2826
Authors:
DUBRAY B
HENRYAMAR M
MEERWALDT JH
NOORDIJK EM
DIXON DO
COSSET JM
THAMES HD
Citation: B. Dubray et al., RADIATION-INDUCED LUNG DAMAGE AFTER THORACIC IRRADIATION FOR HODGKINS-DISEASE - THE ROLE OF FRACTIONATION, Radiotherapy and oncology, 36(3), 1995, pp. 211-217
Authors:
HERMANS J
KROL ADG
VANGRONINGEN K
KLUIN PM
KLUINNELEMANS JC
KRAMER MHH
NOORDIJK EM
ONG F
WIJERMANS PW
Citation: J. Hermans et al., INTERNATIONAL PROGNOSTIC INDEX FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA IS VALID FOR ALL MALIGNANCY GRADES, Blood, 86(4), 1995, pp. 1460-1463